Search results for "nations"

showing 10 items of 483 documents

Fluticasone propionate/formoterol: a fixed-combination therapy with flexible dosage.

2014

International guidelines describe asthma control as the main outcome of asthma management. Prevention of symptoms, improved quality of life, and reduction of exacerbations are the main components, consequently decreasing health care costs. However, many of these objectives remain unmet in real life: several surveys show that a large proportion of asthmatic patients are not well controlled despite the efficacy of current available treatment. Several randomized controlled clinical trials indicate that combining inhaled corticosteroids and long-acting β2-agonists, by means of a single inhaler, greatly improves the management of the disease. The results of 9 multicenter phase III clinical studi…

medicine.medical_specialtyCombination therapyAsthma exacerbationSettore MED/10 - Malattie dell'Apparato RespiratorioSettore MED/10 - Malattie Dell'Apparato RespiratorioFluticasone propionateAsthma control; Asthma exacerbations; Fixed-combination therapy; Fluticasone propionate/formoterol; Single-aerosol inhalerAsthma controlFluticasone propionate/formoterolForced Expiratory VolumeFormoterol FumarateInternal MedicineMedicineHumansAnti-Asthmatic AgentsAsthma exacerbationsParticle SizeIntensive care medicineAsthmaFluticasonebusiness.industryInhalerNebulizers and VaporizersFixed-combination therapyAsthma control; Asthma exacerbations; Fixed-combination therapy; Fluticasone propionate/formoterol; Single-aerosol inhaler; Androstadienes; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Drug Combinations; Ethanolamines; Fluticasone; Forced Expiratory Volume; Formoterol Fumarate; Humans; Nebulizers and Vaporizers; Particle Size; Quality of Life; Treatment Outcomemedicine.diseaseSingle-aerosol inhalerAsthmaBronchodilator AgentsAndrostadienesDrug CombinationsTreatment OutcomeTolerabilityAsthma control Asthma exacerbations Fixed-combination therapy Fluticasone propionate/formoterol Single-aerosol inhalerEthanolaminesAnesthesiaAsthma exacerbations; Asthma control; Fixed-combination therapy; Fluticasone propionate/formoterol; Single-aerosol inhalerQuality of LifeFluticasoneFormoterol FumarateFormoterolbusinessmedicine.drugEuropean journal of internal medicine
researchProduct

Impact of COVID-19 pandemic on acute heart failure admissions and mortality: a multicentre study (COV-HF-SIRIO 6 study)

2022

Abstract Aims The coronavirus disease‐2019 (COVID‐19) pandemic has changed the landscape of medical care delivery worldwide. We aimed to assess the influence of COVID‐19 pandemic on hospital admissions and in‐hospital mortality rate in patients with acute heart failure (AHF) in a retrospective, multicentre study. Methods and results From 1 January 2019 to 31 December 2020, a total of 101 433 patients were hospitalized in 24 Cardiology Departments in Poland. The number of patients admitted due to AHF decreased by 23.4% from 9853 in 2019 to 7546 in 2020 (P < 0.001). We noted a significant reduction of self‐referrals in the times of COVID‐19 pandemic accounting 27.8% (P < 0.001), with increase…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Heart failureMedical careLevodopaCOVID‐19Internal medicinePandemicmedicineHumansDiseases of the circulatory (Cardiovascular) systemIn patientPandemicsRetrospective StudiesSARS-CoV-2business.industryMortality rateCarbidopaCOVID-19Original Articlesmedicine.diseaseIn‐hospital mortalityHospitalizationDrug CombinationsIn-hospital mortalityRC666-701Heart failureConcomitantAcute DiseaseOriginal ArticleCardiology and Cardiovascular MedicinebusinessHospital stayESC heart failure
researchProduct

Association between CCK-AR gene and schizophrenia with auditory hallucinations

2007

[Objective]: Previous studies on a possible association between CCK-AR polymorphisms and schizophrenia have been controversial. The aim of the present study was to assess a potential association between schizophrenic patients with auditory hallucinations and polymorphisms of the CCK-AR gene.

medicine.medical_specialtyGenotypeHallucinationsSingle-nucleotide polymorphismAuditory hallucinationsRegulatory Sequences Nucleic Aciddigestive systemPolymorphism Single NucleotideGene FrequencyReference ValuesInternal medicineGenotypeGene expressionGeneticsmedicineHumansSNPCCK-AR geneAllelePsychiatryGeneBiological PsychiatryGenetics (clinical)DNA Primersbusiness.industrydigestive oral and skin physiologyHaplotypeDNAmedicine.diseaseReceptor Cholecystokinin APsychiatry and Mental healthEndocrinologySchizophreniaSchizophreniaSchizophrenic Psychologybusinesshormones hormone substitutes and hormone antagonistsPsychiatric Genetics
researchProduct

Molecular Surveillance of HIV-1 in Madrid, Spain: a Phylogeographic Analysis ▿

2011

ABSTRACT The molecular epidemiology of HIV-1 is constantly changing, mainly as a result of human migratory flows and the high adaptive ability of the virus. In recent years, Spain has become one of Europe's main destinations for immigrants and one of the western European countries with the highest rates of HIV-positive patients. Using a phylogeographic approach, we have analyzed the relationship between HIV-1 variants detected in immigrant and native populations of the urban area of Madrid. Our project was based on two coincidental facts. First, resistance tests were extended to naïve and newly diagnosed patients, and second, the Spanish government legislated the provision of legal status t…

medicine.medical_specialtyGenotypemedia_common.quotation_subjectImmunologyImmigrationMolecular Sequence DataHuman immunodeficiency virus (HIV)HIV InfectionsBiologyDestinationsmedicine.disease_causeMicrobiologylaw.invention03 medical and health sciences0302 clinical medicinePopulation GroupslawVirologyEpidemiologymedicinePrevalenceCluster AnalysisHumans030212 general & internal medicine030304 developmental biologymedia_commonTransients and Migrants0303 health sciencesMolecular EpidemiologyMolecular epidemiologySequence Analysis DNA3. Good healthPhylogeographyPhylogeographyTransmission (mechanics)Genetic Diversity and EvolutionSpainpol Gene Products Human Immunodeficiency VirusInsect ScienceCohortHIV-1Demography
researchProduct

Transfusion transmitted leishmaniasis. What to do with blood donors from endemic areas?

2014

Summary Leishmaniasis clinical spectrum ranges from cryptic infection to fatal visceral leishmaniasis. Cryptic infection can be found in blood donors from areas endemic for leishmaniasis all over the world. Although leishmaniasis is a classic vector-borne disease, cases of transfusion transmitted leishmaniasis have been reported especially in nonendemic areas. Most of these cases regarded infants or children. This paper reviews the literature on this specific feature and the impact of leishmaniasis on transfusion medicine. Relevant literature was found through PubMed. The reference lists of selected articles identified further sources. Conclusions: Blood donations by emigrants or travelers f…

medicine.medical_specialtyLeishmaniasiSettore MED/09 - Medicina InternaBlood DonorsDiseaseBlood donationsmedicineAnimalsHumansTravel medicineBlood TransfusionIntensive care medicineLeishmaniabiologyTransfusion Medicinebusiness.industryPublic Health Environmental and Occupational HealthTransfusion medicineLeishmaniasismedicine.diseaseLeishmaniabiology.organism_classificationtransfusion blood donorCryptic infectionBloodInfectious DiseasesVisceral leishmaniasisLeishmaniasis; transfusion blood donors;ImmunologyLeishmaniasis Visceralbusiness
researchProduct

The nephroprotective effect of sacubitril/valsartan in heart failure: insights from the real-life clinical setting

2019

Real-life data confirming the favourable renal outcome in patients with heart failure (HF) treated with Sacubitril/Valsartan, previously found in several trials (RCTs), are still scant. We evaluated the renal effects of Sacubitril/Valsartan in a real-life sample of HF patients. Observational analysis of 54 consecutive outpatients affected by HF with reduced ejection fraction (HFrEF) and clinical indication for Sacubitril/Valsartan. Patients were evaluated at baseline (T0) and after six (T6) and twelve (T12) months after initiating Sacubitril/Valsartan and compared with a group of 30 historical controls. Mean age: 65.5 ± 11.7 years. Older patients: 29 (53.7%). Mean baseline estimated glomeru…

medicine.medical_specialtyMEDLINETetrazolesHeart failureLifeInternal MedicinemedicineHumansKidney dysfunctionSacubitril-ValsartanIntensive care medicinebusiness.industryAminobutyratesBiphenyl CompoundsFollow up studiesSacubitril/Valsartanmedicine.diseaseIm - OriginalDrug CombinationsValsartanHeart failureBlood pressureEmergency MedicineValsartanbusinessSacubitril ValsartanFollow-Up StudiesRenal functionmedicine.drug
researchProduct

Musculoskeletal examination in young athletes and non-athletes:the Finnish Health Promoting Sports Club (FHPSC) study

2018

ObjectivesTo determine the inter-rater repeatability of a musculoskeletal examination and to compare findings between adolescent athletes and non-athletes in Finland.MethodsIn this cross-sectional study, a musculoskeletal examination assessing posture, mobility and movement control was carried out by a sports and exercise medicine physician on 399 athletes aged 14–17 years and 177 non-athletes. Within 2 weeks another sports and exercise medicine physician repeated the examination for 41 adolescents to test the inter-rater repeatability.ResultsIn total, 10 of the 11 tests performed had at least moderate inter-rater reliability (κ ≥0.4 or percentage agreement &gt;80%). Athletes more often tha…

medicine.medical_specialtyPhysical Therapy Sports Therapy and RehabilitationSquatmusculoskeletal examinations03 medical and health sciences0302 clinical medicinenuoretMusculoskeletal examinationmedicinemotor controlthe Finnish Health Promoting Sports Club studyOrthopedics and Sports Medicine030212 general & internal medicine1506movement/physiologyMovement controlryhtiCore (anatomy)biologypostural balance/physiologyAthletesbusiness.industrymittausMotor controlkehonhallinta030229 sport sciencesbiology.organism_classificationFHPSC studytestingobserver variationTest (assessment)musculoskeletal examinationadolescentPhysical therapymovement controlnon-athletesOriginal ArticleClubathletereproducibility of resultsbusinesslihaskuntoperiodic health evaluationurheilijat
researchProduct

Impact of donor-recipient age on cardiac transplant survival. Subanalysis of the Spanish Heart Transplant Registry.

2020

[Abstract] Introduction and objectives. The age of heart transplant recipients and donors is progressively increasing. It is likely that not all donor-recipient age combinations have the same impact on mortality. The objective of this work was to compare survival in transplant recipients according to donor-recipient age combinations. Methods. We performed a retrospective analysis of transplants performed between 1 January 1993 and 31 December 2017 in the Spanish Heart Transplant Registry. Pediatric transplants, retransplants and combined transplants were excluded (6505 transplants included). Four groups were considered: a) donor < 50 years for recipient < 65 years; b) donor < 50 years for r…

medicine.medical_specialtyPrognostic factorTrasplante cardiacoMultivariate analysisSurvivalCombinaciones de edad de donante y receptor Donor age Donor/recipient age combinations Edad del donante Edad del receptor Heart transplant Recipient age Supervivencia Survival Trasplante cardiacoEnfermedad cardiovascularDonor/recipient age combinationsRecipient age030204 cardiovascular system & hematologyDonor age03 medical and health sciences0302 clinical medicineInternal medicineRetrospective analysisEdad del receptorMedicineHumansTrasplante de corazónRegistriesChildRetrospective StudiesSupervivenciabusiness.industryEdad del donanteGraft SurvivalAge FactorsCombinaciones de edad de donante y receptorGeneral MedicineTissue DonorsTransplant RecipientsTrasplante de órganosDatos estadísticosHeart TransplantationHeart transplantSupervivencia tisularbusinessMedian survival
researchProduct

Caffeine increases the expression of cystatin SN in human submandibular acinar-like HSG cells

2013

The study aimed at evaluating in vitro the effect of caffeine on expression of cystatin SN, a potential marker of sensitivity to bitterness in humans.Differentiation of human submandibular gland (HSG) cells was induced by culturing cells on Matrigel. Caffeine cytotoxicity was assessed over 3 days by the Resazurin test. Finally, effects of 5, 50 and 100μM caffeine exposure on cystatin SN expression were explored over 3 days by ELISA.At concentrations relevant to human adult plasma levels (5, 50 and 100μM), caffeine did not affect cell viability whether cells were differentiated or not. Cystatin SN levels were overall higher in differentiated cells and increased with time in both conditions. …

medicine.medical_specialtySalivaCellular differentiationeducationCell Culture TechniquesEnzyme-Linked Immunosorbent Assay[SDV.TOX.TCA]Life Sciences [q-bio]/Toxicology/Toxicology and food chain03 medical and health scienceschemistry.chemical_compound0302 clinical medicinestomatognathic systemInternal medicineCaffeinemedicineHumansViability assaySalivaGeneral DentistryBitterness030304 developmental biology0303 health sciencesMatrigelSubmandibular glandChemistryCell BiologyGeneral MedicineSubmandibular glandIn vitroDrug CombinationsEndocrinologymedicine.anatomical_structureOtorhinolaryngologyCell culture030220 oncology & carcinogenesisSalivary CystatinsProteoglycansHSG cell lineCollagenLamininCaffeine
researchProduct

New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension deliver…

2018

COPD causes considerable health and economic burden worldwide, with incidence of the disease expected to continue to rise. Inhaled bronchodilators, such as long-acting muscarinic antagonists (LAMAs) and long-acting β2-agonists (LABAs), are central to the maintenance treatment of patients with COPD. Clinical studies have demonstrated that combined LAMA + LABA therapies improve efficacy while retaining a safety profile similar to LAMA or LABA alone. This has led to the development of several LAMA/LABA fixed-dose combination (FDC) therapies, which provide patients with the convenience of two active compounds in a single inhaler. GFF MDI (Bevespi Aerosphere®) is an FDC of glycopyrrolate/formote…

medicine.medical_specialtymedicine.drug_classDrug CompoundingFixed-dose combinationMuscarinic AntagonistsPulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicineFormoterol FumarateBronchodilatorAdministration InhalationmedicineHumans030212 general & internal medicineIntensive care medicineAdrenergic beta-2 Receptor AgonistsGlycopyrrolateCOPDbiologybusiness.industryInhalerGeneral MedicineLamamedicine.diseasebiology.organism_classificationGlycopyrrolateMetered-dose inhalerBronchodilator AgentsDrug CombinationsTreatment Outcome030228 respiratory systemFormoterolbusinesshormones hormone substitutes and hormone antagonistsmedicine.drugInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct